Type 2 Diabetes-Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets.
Diabetes 2018 Nov; 67(11):2466-2477
Doug Coleman research Fund at The Jackson Laboratory, DK092251, ADA Pathway to Stop Diabetes Accelerator Award 1-18-ACE-15
Type 2 diabetes (T2D) is a complex disorder in which both genetic and environmental risk factors contribute to islet dysfunction and failure. Genome-wide association studies (GWAS) have linked single nucleotide polymorphisms (SNPs), most of which are noncoding, in >200 loci to islet dysfunction and T2D. Identification of the putative causal variants and their target genes and whether they lead to gain or loss of function remains challenging. Here, we profiled chromatin accessibility in pancreatic islet samples from 19 genotyped individuals and identified 2,949 SNPs associated with in vivo
Type 2 Diabetes-Associated Genetic Variants Regulate Chromatin Accessibility in Human Islets. Diabetes 2018 Nov; 67(11):2466-2477